Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 368

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 368
---
 |    — |     |        |
| Sponsor and its affiliates as a group           |     |                   |     |      |     |        |
| 5% or Greater Holders                           |     |                   |     |      |     |        |
| League Jinn Sarl(6)                             |     |         1,325,870 |     | 25.3 |     |        |
| Clover Wolf Capital Limited Partnership(7)      |     |           538,670 |     | 11.7 |     |        |
| Alpha Capital Anstalt(8)                        |     |           459,906 |     | 9.99 |     |        |

____________ *Less than 1% (1)Beneficial ownership is determined in accordance with SEC rules and generally includes voting or investment power with respect to securities. Kadimastem Ordinary Shares subject to options or warrants currently exercisable, or exercisable within 60 days of March 28, 2025, are counted as outstanding for computing the percentage of the individual or entity holding such options or warrants but are not counted as outstanding for computing the percentage of any other individual or entity. (2)Consists of: (i) 1,145,492 Kadimastem Ordinary Shares, (ii) 211,466 Kadimastem Ordinary Shares issuable upon exercise of warrants exercisable within 60 days of March 31, 2025, and (iii) 25,000 Kadimastem Ordinary Shares issuable upon exercise of options vested and exercisable within 60 days of March 28, 2025. (3)Consists of: (i) 367,332 Kadimastem Ordinary Shares restricted share unites exercisable within 60 days of March 28, 2025, and (ii) 72,500 Kadimastem Ordinary Shares issuable upon exercise of options vested and exercisable within 60 days of March 31, 2025. (4)Consists of: (i) 200 Kadimastem Ordinary Shares, and (ii) 2,500 Kadimastem Ordinary Shares issuable upon exercise of options vested and exercisable within 60 days of March 28, 2025. (5)Consists of 240 Kadimastem Ordinary Shares issuable upon exercise of options vested and exercisable within 60 days of March 28, 2025. (6)Consists of (